Literature DB >> 3933809

Predictors of asymptomatic gonorrhea among patients seen by private practitioners.

R Allard, J Robert, P Turgeon, Y Lepage.   

Abstract

Nineteen physicians participating in a program for detecting and treating gonorrhea and other sexually transmitted diseases (STD) in high-risk groups filled out encounter forms for the initial visits by the first 3144 patients. This information was used to describe the program users and, by means of logistic regression analysis, to identify predictors of gonorrhea in asymptomatic patients. Overall, 17.3% of the users had culture-proved gonorrhea. Of the symptomatic patients 24.5% had gonorrhea. Of the asymptomatic patients 20.4% of those with a history of contact with a known or suspected case of STD had the disease, and 5.3% of those without a history of contact had the disease. The independent predictors of gonorrhea identified were, in order of importance, a history of contact with a case of STD and being aged less than 30 years. These predictors underline the importance of contact tracing, an underused but productive method of gonorrhea control that can be used effectively in private practice.

Entities:  

Mesh:

Year:  1985        PMID: 3933809      PMCID: PMC1346370     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  17 in total

1.  Tracing and treating contacts of gonorrhea patients in a clinic for sexually transmitted diseases.

Authors:  F N Judson; F C Wolf
Journal:  Public Health Rep       Date:  1978 Sep-Oct       Impact factor: 2.792

2.  New options for diagnosis and control of gonorrheal urethritis in males using uncentrifuged first voided urine (FVU) as a specimen for culture.

Authors:  E S Murray; M J Benfari; S R Coppola; M D Hughes; W C Feng; R M Medeiros; L J Kunz
Journal:  Am J Public Health       Date:  1979-06       Impact factor: 9.308

3.  Screening for gonorrhea and syphilis in the gay baths--Denver, Colorado.

Authors:  F N Judson; K G Miller; T R Schaffnit
Journal:  Am J Public Health       Date:  1977-08       Impact factor: 9.308

4.  The experience of the Howard Brown Memorial Clinic of Chicago with sexually transmitted diseases.

Authors:  D G Ostrow; D M Shaskey
Journal:  Sex Transm Dis       Date:  1977 Apr-Jun       Impact factor: 2.830

5.  Health advisers (contact tracers) in sexually transmitted disease.

Authors:  R N Thin
Journal:  Br J Vener Dis       Date:  1984-08

6.  How to control gonorrhea: the view of a local public health officer.

Authors:  F N Judson
Journal:  Sex Transm Dis       Date:  1979 Jul-Sep       Impact factor: 2.830

7.  Orogenital contact and the isolation of Neisseria gonorrhoeae, Mycoplasma hominis, and Ureaplasma urealyticum from the pharynx.

Authors:  S G Sackel; S Alpert; N J Fiumara; A Donner; C A Laughlin; W M McCormack
Journal:  Sex Transm Dis       Date:  1979 Apr-Jun       Impact factor: 2.830

8.  A rational basis for the epidemiologic treatment of gonorrhea in a clinic for sexually transmitted diseases.

Authors:  F N Judson; A B Maltz
Journal:  Sex Transm Dis       Date:  1978 Jul-Sep       Impact factor: 2.830

9.  Rapid carbohydrate utilization test for the identification of Neisseria gonorrhoeae.

Authors:  H Young; I C Paterson; D R McDonald
Journal:  Br J Vener Dis       Date:  1976-06

10.  Intensive screening for gonorrhea, syphilis, and hepatitis B in a gay bathhouse does not lower the prevalence infection.

Authors:  F C Wolf; F N Judson
Journal:  Sex Transm Dis       Date:  1980 Apr-Jun       Impact factor: 2.830

View more
  2 in total

1.  A new diagnostic index for predicting cervical infection with either Chlamydia trachomatis or Neisseria gonorrhoeae.

Authors:  G E Rosenthal; G Mettler; S Pare; M Riegger; M Ward; C S Landefeld
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

2.  Predictors of chlamydial infection and gonorrhea among patients seen by private practitioners.

Authors:  J Vincelette; J G Baril; R Allard
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.